Trexquant Investment LP Purchases 604,116 Shares of Teladoc Health, Inc. $TDOC

Key Points

• Trexquant Investment LP increased its holdings in Teladoc Health, Inc. by 198.9% during Q1 2023, now owning approximately 0.52% of the company worth $7.23 million.
• Several other hedge funds also made significant changes to their positions in Teladoc Health, with institutional investors now owning 76.82% of the stock.
• Analysts have mixed views on Teladoc Health, with a consensus rating of "Hold" and varying price targets, the highest being $10.00 and the lowest at $7.00.

Trexquant Investment LP grew its holdings in Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 198.9% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 907,859 shares of the health services provider's stock after purchasing an additional 604,116 shares during the period. Trexquant Investment LP owned approximately 0.52% of Teladoc Health worth $7,227,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the business. Golden State Wealth Management LLC raised its position in shares of Teladoc Health by 102.6% during the 1st quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider's stock valued at $27,000 after acquiring an additional 1,690 shares during the last quarter. National Bank of Canada FI grew its stake in shares of Teladoc Health by 79.4% in the first quarter. National Bank of Canada FI now owns 3,571 shares of the health services provider's stock worth $28,000 after purchasing an additional 1,581 shares during the last quarter. SVB Wealth LLC acquired a new position in shares of Teladoc Health during the first quarter valued at about $37,000. BI Asset Management Fondsmaeglerselskab A S bought a new stake in Teladoc Health in the 1st quarter worth about $50,000. Finally, Quantitative Investment Management LLC bought a new position in Teladoc Health in the 1st quarter worth approximately $82,000. 76.82% of the stock is currently owned by institutional investors.

Teladoc Health Stock Up 2.3%

Shares of NYSE:TDOC traded up $0.18 during midday trading on Friday, hitting $7.81. 2,091,381 shares of the company's stock traded hands, compared to its average volume of 6,814,440. The firm's fifty day moving average price is $7.79 and its two-hundred day moving average price is $7.89. The company has a market cap of $1.38 billion, a PE ratio of -6.56 and a beta of 1.84. Teladoc Health, Inc. has a twelve month low of $6.35 and a twelve month high of $15.21. The company has a debt-to-equity ratio of 0.70, a quick ratio of 2.58 and a current ratio of 2.67.

Teladoc Health (NYSE:TDOC - Get Free Report) last released its quarterly earnings results on Tuesday, July 29th. The health services provider reported ($0.19) EPS for the quarter, topping analysts' consensus estimates of ($0.27) by $0.08. The company had revenue of $631.90 million for the quarter, compared to the consensus estimate of $621.91 million. Teladoc Health had a negative net margin of 8.16% and a negative return on equity of 10.13%. Teladoc Health's revenue was down 1.6% on a year-over-year basis. During the same period in the previous year, the firm earned ($0.38) EPS. Teladoc Health has set its Q3 2025 guidance at -0.350--0.200 EPS. FY 2025 guidance at -1.350--1.000 EPS. On average, equities research analysts anticipate that Teladoc Health, Inc. will post -1.16 EPS for the current fiscal year.

Analyst Ratings Changes

A number of brokerages have weighed in on TDOC. Evercore ISI upped their price objective on shares of Teladoc Health from $7.00 to $8.00 and gave the stock an "in-line" rating in a report on Wednesday, July 9th. Mizuho assumed coverage on Teladoc Health in a report on Friday, July 25th. They issued a "neutral" rating and a $10.00 price target on the stock. Truist Financial dropped their target price on Teladoc Health from $10.00 to $9.00 and set a "hold" rating on the stock in a research report on Tuesday, May 27th. Wells Fargo & Company reduced their target price on Teladoc Health from $10.00 to $8.00 and set an "equal weight" rating for the company in a research note on Thursday, May 8th. Finally, Bank of America cut their price target on Teladoc Health from $8.00 to $7.00 and set a "neutral" rating for the company in a research note on Wednesday, May 28th. Six investment analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus target price of $9.80.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.